View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 400, Non-Small Cell Lung Cancer, First Line
Protocol-ID: 1252 V1.0 (Mini), PEMB400, NSCLC, first-lineIndication(s)
- Lung Carcinoma, Non-Small Cell (PD-L1 >50%); ICD-10 C34.-
Links
- Pembrolizumab [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 22.05.2019